| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |